Overview

A Clinical Trial to Evaluate the Efficacy and Safety of Generic Escitalopram in Depression

Status:
Completed
Trial end date:
2010-03-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to evaluate the efficacy and safety of Generic Escitalopram in the treatment of Chinese patients with depression compared with Innovator Escitalopram(Lexapro®) by evaluating the change of HAMD-17 total score from the baseline to week 8.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Shanghai Mental Health Center
Collaborator:
Jiangsu Nhwa Pharmaceutical Co., Ltd.
Treatments:
Citalopram
Dexetimide